Rockefeller Capital Management
PRAX icon

Rockefeller Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Rockefeller Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Hold
315
– – ﹤0.01% 2960
2026
Q1 		$101K Buy
315
+251
+392% +$77.6K ﹤0.01% 2864
2025
Q4 		$18.9K Buy
64
+62
+3,100% +$11.5K ﹤0.01% 3536
2025
Q3 		$106 Buy
+2
New +$97 ﹤0.01% 4374
2023
Q1 		– Sell
-4
Closed – – 3403
2022
Q4 		$0 Sell
4
-29
-88% -$904 ﹤0.01% 4138
2022
Q3 		$1K Sell
33
-11
-25% -$548 ﹤0.01% 3772
2022
Q2 		$1K Buy
44
+13
+42% +$1.39K ﹤0.01% 3996
2022
Q1 		$4K Buy
31
+3
+11% +$616 ﹤0.01% 3436
2021
Q4 		$8K Buy
28
+1
+4% +$293 ﹤0.01% 3093
2021
Q3 		$7K Hold
27
– – ﹤0.01% 3054
2021
Q2 		$7K Buy
+27
New +$9.67K ﹤0.01% 2931

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Rockefeller Capital Management's PRAX Position: Q2 2026 in Review

Rockefeller Capital Management held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 315 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2960.

Rockefeller Capital Management first reported a position in PRAX in Q2 2021 and has held it in 11 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Rockefeller Capital Management held 315 shares of Praxis Precision Medicines worth $105K as of Q2 2026.
  • Rockefeller Capital Management left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2960 holding.
  • Rockefeller Capital Management first reported a position in Praxis Precision Medicines in Q2 2021 and has held it in 11 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.